ModivCare Inc MODV.OQ MODV.O is expected to show a fall in quarterly revenue when it reports results on May 8 for the period ending March 31 2025
The Denver Colorado-based company is expected to report a 5.6% decrease in revenue to $645.865 million from $684.45 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for ModivCare Inc is for a loss of 50 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts had risen by about 120.0% in the last three months.
Wall Street's median 12-month price target for ModivCare Inc is $4.75, above its last closing price of $1.41.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Dec. 31 2024 | -0.02 | 0.18 | 0.19 | Beat | 8 |
Sep. 30 2024 | 0.58 | 0.78 | 0.45 | Missed | -41.9 |
Jun. 30 2024 | 0.80 | 0.77 | -0.03 | Missed | -103.9 |
Mar. 31 2024 | 0.24 | 0.19 | -0.09 | Missed | -146.6 |
Dec. 31 2023 | 1.32 | 1.28 | 1.29 | Beat | 0.9 |
Sep. 30 2023 | 1.17 | 1.11 | 1.44 | Beat | 29.3 |
Jun. 30 2023 | 1.71 | 1.62 | 1.47 | Missed | -9.3 |
Mar. 31 2023 | 1.54 | 1.50 | 1.42 | Missed | -5 |
This summary was machine generated May 6 at 21:03 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。